Serum-free process development: improving the yield and consistency of human mesenchymal stromal cell production

We have increased the yield and consistency of BM-hMSC expansion between donors, demonstrating a level of control over the product, which has the potential to increase the cost-effectiveness and reduce the risk in these manufacturing processes.